Weidong Yin
Sinovac Biotech(CN)
Publications by Year
Research Areas
SARS-CoV-2 and COVID-19 Research, Viral gastroenteritis research and epidemiology, Viral Infections and Immunology Research, Influenza Virus Research Studies, COVID-19 Clinical Research Studies
Most-Cited Works
- → Development of an inactivated vaccine candidate for SARS-CoV-2(2020)1,508 cited
- → Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18–59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial(2020)1,500 cited
- → Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine (CoronaVac) in healthy adults aged 60 years and older: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial(2021)574 cited
- → A sensor-adaptor mechanism for enterovirus uncoating from structures of EV71(2012)393 cited
- → Probable limited person-to-person transmission of highly pathogenic avian influenza A (H5N1) virus in China(2008)289 cited
- → Immunogenicity and safety of a third dose of CoronaVac, and immune persistence of a two-dose schedule, in healthy adults: interim results from two single-centre, double-blind, randomised, placebo-controlled phase 2 clinical trials(2021)285 cited
- → Safety and immunogenicity of an inactivated adjuvanted whole-virion influenza A (H5N1) vaccine: a phase I randomised controlled trial(2006)258 cited
- → Safety and immunogenicity of 2009 pandemic influenza A H1N1 vaccines in China: a multicentre, double-blind, randomised, placebo-controlled trial(2009)254 cited
- → Hepatitis A virus and the origins of picornaviruses(2014)195 cited
- → Safety and Immunogenicity from a Phase I Trial of Inactivated Severe Acute Respiratory Syndrome Coronavirus Vaccine(2007)168 cited